Skip to content
Search

Latest Stories

Leading pharmacist honoured for contributions to the Nigerian medical community

Professor Mahendra Patel was felicitated by the Nigerian Medical Association across Great Britain

Senior academic pharmacist, Professor Mahendra Patel, recently received an award for his outstanding contribution and support for the Nigerian community in the UK.


The Medical Association of Nigerians across GB (MANSAG) conducted its two-day annual General and Scientific Conference on October 27 and 28 in London.

The theme of the conference focussed on “Transforming Health Outcomes” to celebrate the contributions Nigerian doctors make to healthcare systems in the UK and globally.

Dr Patel delivered an inspiring keynote speech on “Making clinical research equitable for the UK Nigerian community”.

The speech was designed to explore the challenges, solutions, and successes influencing research programmes aimed at transforming health outcomes for the Black, Asian and ethnic minority communities. 

Moreover, he has also extended his support for helping to tackle the decades of “health inequalities faced by Black and South Asian communities through a concerted effort to make research more inclusive and equitable.  

Dr Patel expressed his gratitude to Pharmacy Business, saying: “Engaging with MANSAG, the Medical Association of Nigerians across GB at their annual conference, and to some extent initially feeling anxious butsoon becoming an integral and valued member of this very welcoming andhighlyreceptive Nigerian community.

"It was notably one of the most uplifting and inspiring experiences I’ve ever had when it comes to working with and engaging communities from diverse backgrounds. 

IMG 20231101 WA0012 Dr Chris Agbo, the president of MANSAG. Credit: Mahendra Patel

He further added: “For decades, and even today, we continue to label certain communities as not wanting to come forward when it comes to engaging in clinical research for various reasons including previous experiences, mistrust, lack of communication etc.

 “Yet, I found quite the opposite with this Nigerian community who want to be involved and be supportive in every sense. We just need to make the right kind of efforts to engage with them,“ he said.  

“We have to invest long term with time, resource, and energy if we are to genuinely understand diversity, cultural behaviours and attitudes and to build strong bridges through community outreach work that are meaningful in helping address inequity in both health and research. This is a fabulous opportunity through pharmacy as part of the national IPP plans.

“Whilst all awards are special, this one from MANSAG was special and different. I’m humbled, to say the least, and deeply grateful to the Nigerian community for honouring and recognising our outreach work with the community. It will have a special place in my home and my heart," he said.

Dr Patel believes that “building trust from very low levels needs sustained and dedicated investment with robust support and proper means of community outreach work if we’re to effectivelyand genuinely address the decades of health inequalities that Black and South Asian and ethnic minority communities have had to live with.” 

MANSAG's president, Dr Chris Agbo, hailed Patel for his work, he said: “It was an absolute pleasure to have Professor Mahendra Patel from the University Of Oxford at the annual conference.

“It is rapidly becoming a very strong and unique collaboration helping to raise the awareness of the importance of research equity and engaging the Nigerian community in clinical trials in ensuring research is more representative and meaningful.

He added: “It’s important Nigerians and the wider Black community is involved from the developing stages of research, the delivery of research and the taking part in research as participants if we are to help address health inequalities more effectively truly.

“We are very grateful for the work Prof Patel and colleagues are doing, and as MANSAG we are all looking forward to this exciting collaboration between MANSAG and Centre for Research Equity at Oxford.”

In 2021, Dr Patel Professor Patel was recognised in Queen Elizabeth’s annual New Year’s honours list, and was awarded an OBE for his “services to pharmacy.”

Moreover, he played a leading role in the national urgent and priority public health with thePrinciple and Panoramic trials for COVID-19 led by Oxford University. 

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less